Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Acta Haematologica
|
April 4, 2019
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma
Boaz Nachmias, Adir Shaulov, David Lavie, et al.
Andrologia
|
August 20, 2020
Parameters associated with sperm quality prior to chemotherapy in lymphoma patients
Gilad Karavani, Nissan Feigin, Tzipora Tachover, et al.
Integrative Cancer Therapies
|
June 4, 2015
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia
Moshe E Gatt, Jacob Strahilevitz, Nir Sharon, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2024
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events
Limor Rubin, Aviv Talmon, Yaarit Ribak, et al.
Cancer Chemotherapy and Pharmacology
|
April 9, 2016
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy
Neta Goldschmidt, Geffen Kleinstern, Marina Orevi, et al.
American Journal of Hematology
|
November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy
Adir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
European Journal of Haematology
|
February 18, 2018
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
Marjorie Pick, Vladimir Vainstein, Neta Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 19, 2018
Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study
Adi Shacham-Abulafia, Pia Raanani, David Lavie, et al.
Blood Advances
|
July 16, 2025
Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma
Philippe Armand, Pier Luigi Zinzani, John M Timmerman, et al.
Leukemia & Lymphoma
|
February 15, 2014
Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
Jacob Vine, Sara Bar Cohen, Rosa Ruchlemer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Acta Haematologica
|
April 4, 2019
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma
Boaz Nachmias, Adir Shaulov, David Lavie, et al.
Andrologia
|
August 20, 2020
Parameters associated with sperm quality prior to chemotherapy in lymphoma patients
Gilad Karavani, Nissan Feigin, Tzipora Tachover, et al.
Integrative Cancer Therapies
|
June 4, 2015
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia
Moshe E Gatt, Jacob Strahilevitz, Nir Sharon, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2024
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events
Limor Rubin, Aviv Talmon, Yaarit Ribak, et al.
Cancer Chemotherapy and Pharmacology
|
April 9, 2016
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy
Neta Goldschmidt, Geffen Kleinstern, Marina Orevi, et al.
American Journal of Hematology
|
November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy
Adir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
European Journal of Haematology
|
February 18, 2018
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
Marjorie Pick, Vladimir Vainstein, Neta Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 19, 2018
Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study
Adi Shacham-Abulafia, Pia Raanani, David Lavie, et al.
Blood Advances
|
July 16, 2025
Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma
Philippe Armand, Pier Luigi Zinzani, John M Timmerman, et al.
Leukemia & Lymphoma
|
February 15, 2014
Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
Jacob Vine, Sara Bar Cohen, Rosa Ruchlemer, et al.
Page
of 3